100% Locally Owned, Independent and Free

100% Locally Owned, Independent and Free

University to head trials for 'three-in-one' investigational vaccine

Do you have a news tip? Click here to send to our news team.

Landmark tourism property earmarked for expansion

The new owners of a popular holiday destination have revealed plans to add more accommodation, just months after buying the property. G'day Group, which operates More

Scrapped waste service back on council agenda

An annual waste collection service discontinued after being suspended during the pandemic could be formally reconsidered amid continued calls for its return. Noosa councillor Amelia More

Parents reach out amid hidden struggles

Scores of Sunshine Coast parents have sought specialist support this year as they navigate the mental health pressures of pregnancy and life with a More

Ashley Robinson: 42 years of marital bliss

This may surprise you, but I have been married to my wonderful wife for 42 years – just clocked over last week. In this column, More

Peak-hour traffic hit by crash

A man has been taken to hospital with burns after a vehicle crashed into a traffic pole and caught fire on the Sunshine Coast. The More

Design contract awarded as transport project progresses

The design and pre-construction contract has been revealed for a planned 7km section of rail line on the Sunshine Coast, along with new impressions More

The University of the Sunshine Coast will lead trials for an investigational vaccine that could address three viruses, including COVID-19.UniSC Clinical Trials staff will enrol participants in a Moderna phase 1 trial, of a combination investigational vaccine for COVID-19, influenza and respiratory syncytial virus at its South Bank clinic in Brisbane.This will be the third time UniSC Clinical Trials conducts a trial for Moderna, to evaluate its mRNA technology.

Principal investigator Dr Nischal Sahai will oversee the trial that will assess the safety and immunogenicity of the investigational vaccine.Dr Sahai said the study presented the opportunity to evaluate the potential of investigational combination mRNA vaccines.“The investigational vaccine will be evaluated to see if it can help to reduce the burden of respiratory disease and offer the community the opportunity to be vaccinated for common respiratory viruses with one single dose and a yearly booster thereafter,” he said.“This is an investigational mRNA vaccine which contains acids that are naturally found in our body’s cells. We hope that it will instruct the body to make antibodies when exposed to these three respiratory viruses.”

UniSC will lead the trials. Picture: Shutterstock.

The study requires healthy volunteers between the ages of 50 and 75. Participants will be asked to attend seven clinic visits and eight phone calls over a period of up to 13 months.“The investigational vaccine will be administered by injection into the upper arm muscle, like the annual influenza vaccine,” Dr Sahai said.“It is hoped that by combining the vaccines for these three respiratory viruses there could be increased protection for older people due to the ease at which it could be accessed; much like paediatric vaccines, as well as potentially increasing compliance,” he said.Eligible participants will be paid for their time on the study. Those interested in volunteering can find more information at USC – trials. 

Like stories about Sunshine Coast people doing great things? Help us deliver more by registering for our free daily news feed. All it requires is your name and email. See SUBSCRIBE at the top of this article.

Subscribe to SCN’s free daily news email

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
[scn_go_back_button] Return Home
Share